Abstract | ETHNOPHARMACOLOGICAL RELEVANCE: MATERIALS AND METHODS: In the present study, we examined the anti- tumor activity of the fermented culture broth of Antrodia salmonea (AS) in vitro and in vivo and revealed its underlying molecular mechanism of action. RESULTS: Treatment of human promyelocytic leukemia (HL-60) cells with AS (50-150 μg/mL) significantly reduced cell viability and caused G1 arrest via the inhibition of cell-cycle regulatory proteins, including cyclin D1, CDK4, cyclin E, cyclin A, and phosphorylated retinoblastoma protein (p-Rb). Furthermore, AS treatment induced apoptosis, which was associated with DNA fragmentation, followed by a sequence of events, including intracellular ROS generation; mitochondrial dysfunction; Fas ligand activation; cytochrome c release; caspase-3, -8, -9, and PARP activation; and Bcl-2/Bax dysregulation. The results of the in vitro study suggested that AS-induced apoptosis in HL-60 cells was mediated by both the mitochondrial and death receptor pathways. Furthermore, we found that AS treatment was effective in delaying tumor incidence in HL-60 xenografted nude mice and reducing tumor burden. CONCLUSIONS: To the best of our knowledge, this is the first report confirming the anti- tumor activity of this potentially beneficial mushroom against human promyelocytic leukemia.
|
Authors | You-Cheng Hseu, Chuan-Chen Lee, Yung-Chang Chen, K J Senthil Kumar, Chee-Shan Chen, Yu-Chi Huang, Li-Sung Hsu, Hui-Chi Huang, Hsin-Ling Yang |
Journal | Journal of ethnopharmacology
(J Ethnopharmacol)
Vol. 153
Issue 2
Pg. 499-510
(Apr 28 2014)
ISSN: 1872-7573 [Electronic] Ireland |
PMID | 24631961
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014. Published by Elsevier Ireland Ltd. |
Chemical References |
|
Topics |
- Animals
- Antineoplastic Agents
(isolation & purification, pharmacology, therapeutic use)
- Antrodia
(isolation & purification)
- Apoptosis
(drug effects, physiology)
- Cell Line
- Dose-Response Relationship, Drug
- Female
- G1 Phase Cell Cycle Checkpoints
(drug effects, physiology)
- HL-60 Cells
- Humans
- Leukemia, Promyelocytic, Acute
(drug therapy, pathology)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Xenograft Model Antitumor Assays
(methods)
|